This study collects exhaled breath condensate samples from healthy populations and hyperlipidemic populations, analyzes the characteristics of the exhaled metabolic lipid profile for early identification of people with abnormal blood lipids, verifies the feasibility and accuracy of a new gas detection method for screening abnormal blood lipids, and explores a simple, fast, and non-invasive method for screening abnormal blood lipids.
Age ≥ 18 years
Voluntarily sign the informed consent form
Patients with lung cancer, asthma, chronic obstructive pulmonary disease, cystic fibrosis, or acute respiratory distress syndrome
Women during pregnancy or breastfeeding
Patients with chronic kidney disease (GFR <60 ml/min) or liver cirrhosis
Individuals unable to cooperate in collecting exhaled breath samples
Healthy population, population with hyperlipidemia
Cohort
Prospective
Lipid Abnormality Mass Spectrometry Screening Model
Diagnostic testBy analyzing the lipid profile in human breath, explore a simple, fast, and non-invasive method for screening dyslipidemia
Sensitivity , specificity , Receiver Operating Characteristic Curve and Area Under Curve of mass spectrometry screening model for dyslipidemia
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
